Detail akcie Archer Explor online

Business Summary: Archer Materials Limited is a quantum technology company building advanced semiconductor devices for quantum computing, quantum sensing, and medical diagnostics. The Company principal activities include technology research and development of the carbon nano onion quantum material (12CQ Project), tunnelling magnetoresistance (TMR) sensor project and graphene-based lab-on-a-chip biosensing chip (biochip) and utilizing semiconductor technology development infrastructure and facilities, research, and development to support technology research and development. The Company is focused on developing its biochip technology, including identifying and developing testing for blood potassium levels, for its first target of hypo- and hyperkalemia detection in chronic kidney disease (CKD) patients. Its biochip marks an inflection point in diagnostics, enabling fast, accurate, and low-cost digital testing.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Archer Materials Ltd revenues was not reported. Net loss increased 45% to A$7M. Higher net loss reflects Share based payments expense increase from A$603K to A$1.9M (expense), Quantum and biochip technology research increase of 6% to A$4.8M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -A$0.02 to -A$0.03.